|
SLC25A16 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.159400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.505400E-01 |
| Normal-vs-Stage2 |
4.811600E-01 |
| Normal-vs-Stage3 |
3.568200E-01 |
| Normal-vs-Stage4 |
8.614400E-01 |
| Stage1-vs-Stage2 |
4.460600E-01 |
| Stage1-vs-Stage3 |
3.058600E-01 |
| Stage1-vs-Stage4 |
9.512000E-01 |
| Stage2-vs-Stage3 |
9.034200E-01 |
| Stage2-vs-Stage4 |
5.114200E-01 |
| Stage3-vs-Stage4 |
4.124600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.344800E-01 |
| Normal-vs-AfricanAmerican |
2.266000E-01 |
| Normal-vs-Asian |
8.958100E-02 |
| Caucasian-vs-AfricanAmerican |
1.174380E-01 |
| Caucasian-vs-Asian |
7.888200E-02 |
| AfricanAmerican-vs-Asian |
5.438400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.716200E-02 |
| Normal-vs-Female |
5.216500E-02 |
| Male-vs-Female |
5.995100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.089800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.705600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.558000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.095800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.703400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.983400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.845400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.760600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.176400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.520200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.068400E-01 |
| Normal-vs-Grade 2 |
6.938600E-01 |
| Normal-vs-Grade 3 |
7.801400E-01 |
| Normal-vs-Grade 4 |
7.779400E-01 |
| Grade 1-vs-Grade 2 |
3.751400E-01 |
| Grade 1-vs-Grade 3 |
3.855600E-01 |
| Grade 1-vs-Grade 4 |
3.788400E-01 |
| Grade 2-vs-Grade 3 |
8.969800E-01 |
| Grade 2-vs-Grade 4 |
9.784600E-01 |
| Grade 3-vs-Grade 4 |
9.096400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.169200E-01 |
| Normal-vs-ccB subtype |
2.467400E-01 |
| ccA subtype-vs-ccB subtype |
1.296570E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.358000E-01 |
| Normal-vs-N1 |
5.106200E-01 |
| N0-vs-N1 |
6.011000E-01 |
|
|
